Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it...
Day: February 19, 2021
CEO of Longeveron Inc. to Present at the Intercontinental Summit on Aging & Gerontology
MIAMI, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
Chugai obtains exclusive development and marketing rights for AT-527 in Japan from Roche, who has ex-US rights for the treatment...
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business Updates
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and...
AREV Engages Dr. Jay Noller to Join the Advisory Board
VANCOUVER, British Columbia, Feb. 19, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is...
Intercept to Present at Upcoming Investor Conferences
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform
Partnerships will use Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody discoveryROCHESTER, N.Y., Feb. 19, 2021...
Integra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami’s Allergy Diagnostics & Allergen Immunotherapy CME Conference
WEST PALM BEACH, FL, Feb. 19, 2021 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”)...
Intra-Cellular Therapies to Present at the SVB Leerink 10th Annual Global Healthcare Conference
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization...
Awakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial
Awakn to Advance Research into Phase IIb TrialLondon, United Kingdom--(Newsfile Corp. - February 19, 2021) - Awakn Life Sciences Inc. announces...
Izotropic Launches New Website and Corporate Presentation
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the...
Clarigent Health Awarded NIH Grant to Advance Technology That Can Evaluate and Remove Potential Biases in Mental Health Algorithms
The grant will help Clarigent Health researchers continue to examine the role demographic and environmental factors play in machine learning...
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for March 4, 2021 at 4:30 p.m. Eastern Time
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable...
New Research Published in the Journal of the American College of Radiology Confirms Black Women More Likely to Receive Inferior Breast Cancer Screening Than White Women, Points to Need for Stronger Breast Health Equity Reform
Review of more than 800,000 mammograms reveals Black women less likely to be screened via digital breast tomosynthesis, despite the...